Where does Advanced Cooling Therapy, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Advanced Cooling Therapy, Inc. ranks #16,552 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Advanced Cooling Therapy, Inc. hold?

Advanced Cooling Therapy, Inc. holds 17 US utility patents granted between 2016 and 2025, spanning 4 technology areas.

What is Advanced Cooling Therapy, Inc.'s Innovation Score?

Advanced Cooling Therapy, Inc. has an Innovation Score of 29.5 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Advanced Cooling Therapy, Inc.'s patent grant rate increasing or decreasing?

Advanced Cooling Therapy, Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Advanced Cooling Therapy, Inc.'s patents?

Advanced Cooling Therapy, Inc.'s patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Advanced Cooling Therapy, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Advanced Cooling Therapy, Inc.

Q: What technology areas does Advanced Cooling Therapy, Inc. focus on?

Advanced Cooling Therapy, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 17 patents, ranking #378 of 3,082 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 17 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Advanced ranks #16,552 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 4 technology areas.

#16,552
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.5/100): 16.6
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16552 · US Corporation #16,552 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #16,552/49,997
PHOTO-FINISH Acceptto
CPC-NARROW A61F · 4 areas
INNOV-THIN 29.5/100
CLAIMS-RICH 16.6 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Acceptto Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Advanced’s 29.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (34%) Velocity 2.5 pts (8%) Breadth 7.1 pts (24%) Claim depth 10.0 pts (34%)

Qualcomm Incorporated · highest

85
Advanced Cooling… · this assignee

30
3D Lighting… · lowest

7

What this shows Advanced's Innovation Score is 29.5/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Advanced?

Each dot is one of Advanced’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Advanced’s own 16.6 claims/patent is at or below the 18.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Advanced vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Advanced's grants concentrate

Advanced Cooling Therapy, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2017. By volume, Advanced sits between Acceptto Corporation and Aker Solutions Limited.

Advanced's three-year grant acceleration

Advanced Cooling Therapy, Inc. shows 3 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Acceptto

17
Accusoft

17
Acmeda Pty

17
Actinium Phamaceu…

17
Advanced Testing

17
Aerosol Dynamics

17
Aetherpal

17
Aker Solutions

17
Advanced Cooling… ◀

17

What this shows Advanced holds 17 patents at rank #16,581, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Advanced

By rank, the assignees closest to #16,581 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Advanced's primary technology class.

Advanced's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Advanced Cooling Therapy, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	11.8%
2017	1	5.9%
2019	4	23.5%
2020	4	23.5%
2023	1	5.9%
2024	2	11.8%
2025partial year	3	17.6%

Which technologies does Advanced Cooling Therapy, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 17

A61B - DIAGNOSIS; SURGERY; Identification 10

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Advanced Cooling Therapy, Inc.'s patent record in context - here's where to go next.

Advanced Cooling Therapy, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #16,552 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Advanced Cooling Therapy, Inc. against Acceptto Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.